The DOL issued guidance on the requirement that group health plans cover the cost of testing with no charge to employees. The plan may not limit this coverage to testing through specified pharmacies or other providers. However, under a DOL safe harbor, the plan may restrict testing through both the plan’s pharmacy network and a direct-to-consumer shipping program, and otherwise limit reimbursement for COVID-19 tests from nonpreferred pharmacies or other retailers to no less than the actual price, or $12 per test (whichever is lower). #IdeaoftheDay
Barbara Weltman
Big Ideas for Small Business, Inc.
Subscribe and download our eBook, "150+ Tax Deductions for Small Business A to Z."
Footer
BOI reporting cont'd. But this isn’t the end of the story. The government filed a notice of appeal with the appellate court, and FinCEN says “deadline stay—voluntary submission only” (https://bit.ly/3ZpKxwU Note: There are cases challenging CTA that are still pending.